Real-world safety and tolerability of fremanezumab in migraine prevention: Final outcomes of the PEARL study

Authors
Category Primary study
Conference19th European Headache Congress, EHC
Year 2026
This article has no abstract
Epistemonikos ID: 99c9cf9384a2905893bcd1b89832a8f4af597974
First added on: Aug 15, 2026